Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

Transforming growth factor-β, bioenergetics, and mitochondria in renal disease.

Casalena G, Daehn I, Bottinger E.

Semin Nephrol. 2012 May;32(3):295-303. doi: 10.1016/j.semnephrol.2012.04.009. Review.

2.

Role of the TGF-β/BMP-7/Smad pathways in renal diseases.

Meng XM, Chung AC, Lan HY.

Clin Sci (Lond). 2013 Feb;124(4):243-54. doi: 10.1042/CS20120252. Review.

PMID:
23126427
3.

Heme oxygenase-1 as a target for TGF-β in kidney disease.

Zarjou A, Agarwal A.

Semin Nephrol. 2012 May;32(3):277-86. doi: 10.1016/j.semnephrol.2012.04.007. Review.

4.

TGF-β/Smad signaling in kidney disease.

Lan HY, Chung AC.

Semin Nephrol. 2012 May;32(3):236-43. doi: 10.1016/j.semnephrol.2012.04.002. Review.

PMID:
22835454
5.

Role of Smad signaling in kidney disease.

Zhang Y, Wang S, Liu S, Li C, Wang J.

Int Urol Nephrol. 2015 Dec;47(12):1965-75. doi: 10.1007/s11255-015-1115-9. Epub 2015 Oct 3. Review.

PMID:
26433882
6.

TGF-β/BMP proteins as therapeutic targets in renal fibrosis. Where have we arrived after 25 years of trials and tribulations?

Muñoz-Félix JM, González-Núñez M, Martínez-Salgado C, López-Novoa JM.

Pharmacol Ther. 2015 Dec;156:44-58. doi: 10.1016/j.pharmthera.2015.10.003. Epub 2015 Oct 19. Review.

PMID:
26493350
7.

Transforming Growth Factor β Superfamily Signaling in Development of Colorectal Cancer.

Jung B, Staudacher JJ, Beauchamp D.

Gastroenterology. 2017 Jan;152(1):36-52. doi: 10.1053/j.gastro.2016.10.015. Epub 2016 Oct 20. Review.

PMID:
27773809
8.

TGF-β signaling via TAK1 pathway: role in kidney fibrosis.

Choi ME, Ding Y, Kim SI.

Semin Nephrol. 2012 May;32(3):244-52. doi: 10.1016/j.semnephrol.2012.04.003. Review.

9.

TGF-β signaling in the kidney: profibrotic and protective effects.

Sureshbabu A, Muhsin SA, Choi ME.

Am J Physiol Renal Physiol. 2016 Apr 1;310(7):F596-F606. doi: 10.1152/ajprenal.00365.2015. Epub 2016 Jan 6. Review.

10.

How does TGF-β mediate tubulointerstitial fibrosis?

Gewin L, Zent R.

Semin Nephrol. 2012 May;32(3):228-35. doi: 10.1016/j.semnephrol.2012.04.001. Review.

11.
12.

Biology of transforming growth factor-β signaling.

Ikushima H, Miyazono K.

Curr Pharm Biotechnol. 2011 Dec;12(12):2099-107. Review.

PMID:
21619537
13.

Diverse roles of TGF-β/Smads in renal fibrosis and inflammation.

Lan HY.

Int J Biol Sci. 2011;7(7):1056-67. Epub 2011 Sep 2. Review.

14.

Transforming growth factor-beta and Smad signalling in kidney diseases.

Wang W, Koka V, Lan HY.

Nephrology (Carlton). 2005 Feb;10(1):48-56. Review.

PMID:
15705182
15.

TGF-β/BMP pathways and the podocyte.

Tossidou I, Schiffer M.

Semin Nephrol. 2012 Jul;32(4):368-76. doi: 10.1016/j.semnephrol.2012.06.008. Review.

PMID:
22958491
16.

Reciprocal regulation of TGF-β and reactive oxygen species: A perverse cycle for fibrosis.

Liu RM, Desai LP.

Redox Biol. 2015 Dec;6:565-77. doi: 10.1016/j.redox.2015.09.009. Epub 2015 Oct 10. Review.

17.

Transforming growth factor-beta signal transduction and progressive renal disease.

Cheng J, Grande JP.

Exp Biol Med (Maywood). 2002 Dec;227(11):943-56. Review.

PMID:
12486204
18.

[Signaling pathways of transforming growth factor beta family members].

Zimowska M.

Postepy Biochem. 2006;52(4):360-6. Review. Polish.

PMID:
17536504
19.

Inhibitory Smad7: emerging roles in health and disease.

Briones-Orta MA, Tecalco-Cruz AC, Sosa-Garrocho M, Caligaris C, Macías-Silva M.

Curr Mol Pharmacol. 2011 Jun;4(2):141-53. Review.

PMID:
21222648
20.

[Transforming growth factor-beta as a therapeutic target].

Gálvez-Gastélum FJ, Sandoval-Rodríguez AS, Armendáriz-Borunda J.

Salud Publica Mex. 2004 Jul-Aug;46(4):341-50. Review. Spanish.

PMID:
15468575

Supplemental Content

Support Center